CorMedix CEO Joseph Todisco reports acquisition of $391,200 in common shares
CRMD•CorMedix CEO and director Joseph Todisco purchased 80,000 common shares at $4.89 each, increasing his direct holdings to 854,749 shares.
CRMD•CorMedix CEO and director Joseph Todisco purchased 80,000 common shares at $4.89 each, increasing his direct holdings to 854,749 shares.
Joseph Todisco purchased 80,000 shares of CorMedix common stock at $4.89 per share, for a total of $391,200. The purchase increased his direct holdings to 854,749 shares.